[JS-2] How to empower current gene and cell therapy approaches by next generation AAV vectors
キーワード：Dr. Büning has a long-standing expertise in the area of viral vector development and infection research. Key competences include cell entry (transductional), transcriptional and genomic targeting of Adeno-Associated Viral (AAV) vectors, vaccine development, and characterization of the AAV-host interaction including immune recognition.
2016年 研究開発局核不拡散科学技術推進室長代行
抄録パスワード認証
参加登録者の皆様へメールにてご案内しております。